BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22904144)

  • 1. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
    Marshall A; Cheetham A; George RS; Mason M; Kelion AD
    Heart; 2012 Sep; 98(18):1359-65. PubMed ID: 22904144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
    Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cardiac
    De Vincentis G; Frantellizzi V; Fedele F; Farcomeni A; Scarparo P; Salvi N; Fegatelli DA; Mancone M; Verschure DO; Verberne HJ
    J Nucl Cardiol; 2019 Aug; 26(4):1188-1196. PubMed ID: 29594915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.
    Verschure DO; Poel E; Travin MI; Henzlova MJ; Jain D; Jacobson AF; Verberne HJ
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1201-1209. PubMed ID: 34427293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac
    Verschure DO; de Groot JR; Mirzaei S; Gheysens O; Nakajima K; van Eck-Smit BLF; Aernout Somsen G; Verberne HJ
    Int J Cardiol; 2017 Dec; 248():403-408. PubMed ID: 28847545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.
    Bax JJ; Kraft O; Buxton AE; Fjeld JG; Parízek P; Agostini D; Knuuti J; Flotats A; Arrighi J; Muxi A; Alibelli MJ; Banerjee G; Jacobson AF
    Circ Cardiovasc Imaging; 2008 Sep; 1(2):131-40. PubMed ID: 19808530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of
    Travin MI; Henzlova MJ; van Eck-Smit BLF; Jain D; Carrió I; Folks RD; Garcia EV; Jacobson AF; Verberne HJ
    J Nucl Cardiol; 2017 Apr; 24(2):377-391. PubMed ID: 26791866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
    García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs.
    Nishisato K; Hashimoto A; Nakata T; Doi T; Yamamoto H; Nagahara D; Shimoshige S; Yuda S; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2010 Aug; 51(8):1241-9. PubMed ID: 20679471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality and utility of [
    Teresińska A; Woźniak O; Maciąg A; Wnuk J; Jezierski J; Fronczak A; Biernacka EK
    Ann Nucl Med; 2021 Aug; 35(8):916-926. PubMed ID: 34023989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiac metaiodobenzylguanidine imaging and QRS duration in implantable cardioverter defibrillator patients with and without heart failure.
    Kawasaki M; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kikuchi A; Kawai T; Seo M; Hirota Kida ; Sakata Y; Fukunami M
    Int J Cardiol; 2019 Dec; 296():164-171. PubMed ID: 31371118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study.
    Giovanni S; Stefano M; Teresa SM; Margherita C; Giovanni B; Umberto P; Paola P; Giacomo C; Pierfranco D; Alfonso G; Riccardo C; Claudio M
    J Nucl Cardiol; 2020 Oct; 27(5):1787-1797. PubMed ID: 30377997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure.
    Clements IP; Kelkar AA; Garcia EV; Butler J; Chen J; Folks R; Jacobson AF
    Eur Heart J Cardiovasc Imaging; 2016 Apr; 17(4):384-90. PubMed ID: 26588983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.
    Sood N; Al Badarin F; Parker M; Pullatt R; Jacobson AF; Bateman TM; Heller GV
    J Nucl Cardiol; 2013 Oct; 20(5):813-20. PubMed ID: 23864400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
    Nagamatsu H; Momose M; Kobayashi H; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Nov; 21(9):513-20. PubMed ID: 18030583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical applications of MIBG SPECT in chronic heart failure].
    Savarese G; Losco T; Parente A; Musella F; Pirozzi E; Mosca S; Casaretti L; Formisano R; Conte S; Bologna A; Mattiello G; Perrone-Filardi P
    G Ital Cardiol (Rome); 2012 Feb; 13(2):91-7. PubMed ID: 22322548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification in heart failure using ¹²³I-MIBG.
    Currie GM; Iqbal B; Wheat JM; Wang L; Trifunovic M; Jelinek HF; Kiat H
    J Nucl Med Technol; 2011 Dec; 39(4):295-301. PubMed ID: 21969356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.